RHEP13 Jan 2011 09:19
Hallmark - have you seen this synospis - it refers to Thunderball and that they are looking for a farm in partner.
http://grayshares.co.uk/graysinvestmentbloguk/2010/09/05/rheochem-swing-back-to-profit-thanks-debt-deal/
A snippet of which is
05/09/2010
In terms of the remaining assets that Zeus has after they had to relinquish most, two are very early exploration targets, the Metis acreage which has an estimated 20-392mmbbls of prospective recoverable resources, and Thunderball which had previously flowed 34mmscf (click here for a gas to barrel of oil equivalent (boe) calculator) on production test. In terms of what they plan to do with these fields, Metis will be relinquished if a farm in partner cannot be found by the December 2010 expiry data, Thunderball on the other hand they expect to keep, and duly expect to gain a farm in partner as some point in the future. Then there is the potential jewel in the crown, via their 10% interest in the Athena block. Rheochem’s 10% interest in Athena gives them 2P reserves of 2.44mmbo, with 3P reserves of 4.39mmbo. So, if recent deals were to be used, with 2P reserves being valued at approximately US$18, this would mean that this 10% stake is worth US$44m (double Rheochem’s current market cap).
But what makes this even more potentially company changing for Rheochem is that production of 22,000 bopd (2,200 bopd net) is expected to begin in 2011, with the FDP approval due by the year end at the very latest. Production of this size for a company of Rheochem’s size, considering that netback is expected at just US$48 a barrel, with cash costs expected to be less than $25 a barrel is quite mouth watering. To explain, if oil stays at US$70 a barrel, then Rheochem at a production of 2,200 bopd would earn a revenue of US$56.2m ((2200 x 70) x 365) in its first year, with a cash flow of US$36m ((2200 x 45) x 365), and a profit of US$17.6m ((2200 x 22) x 365). Of course this revenue will dwindle after the first year as production falls off, but nevertheless, the fact remains that in its first year of production, Athena will earn a greater cash flow than Rheochem’s current market cap.